menu search

Harmony biosciences to present new wakix® (pitolisant) safety and efficacy data at sleep 2023 annual meeting

Late-breaking Phase 2 proof-of-concept study in Prader-Willi syndrome accepted for poster presentation PLYMOUTH MEETING, Pa. , May 10, 2023 /PRNewswir...

May 10, 2023, 8:05 am

Cue biopharma reports first quarter 2023 financial results and recent business highlights

BOSTON, May 09, 2023 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of in...

May 9, 2023, 8:35 pm

Nexcella announces late-breaking nxc-201 clinical data abstract accepted for oral presentation at the 26th annual meeting of the american society of gene and cell therapy (asgct)

•Updated clinical data for next-generation CAR-T NXC-201 in AL amyloidosis will be presented in Los Angeles May 16-20, 2023 LOS ANGELES, May 04, 202...

May 4, 2023, 4:35 pm

2seventy bio to present new preclinical and clinical data from broad portfolio of investigational cell therapies at the asgct 26th annual meeting

CAMBRIDGE, Mass.--(BUSINESS WIRE)--2seventy bio, Inc. (Nasdaq: TSVT), a leading immuno-oncology cell therapy company, today announced the presentation...

May 2, 2023, 4:37 pm

Verona pharma to present expanded analyses of positive phase 3 enhance studies in copd in multiple presentations at ats 2023

12 Abstracts and one Symposium further support potential of ensifentrine, a first-in-class, selective, dual inhibitor of PDE3 and PDE4...

May 2, 2023, 2:00 am

Taysha gene therapies announces presentation on new preclinical data for tsha-102 in rett syndrome at upcoming american society of gene and cell therapy 26th annual meeting

DALLAS, April 27, 2023 (GLOBE NEWSWIRE) — Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage gene therapy company focused on developing an...

April 27, 2023, 8:52 pm

Kalvista pharmaceuticals to present data at the 13th c1-inhibitor deficiency & angioedema workshop

CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)---- $KALV--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical compa...

April 27, 2023, 6:30 am

Tempest announces tpst-1495 poster presentation at the 2023 asco annual meeting

BRISBANE, Calif., April 26, 2023 (GLOBE NEWSWIRE) — Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage oncology company developing first-in...

April 26, 2023, 10:41 pm

Day one announces abstracts accepted for presentation at the 2023 american society of clinical oncology (asco) annual meeting

New clinical data from registrational FIREFLY-1 study to be featured as an oral presentation Trial-in-progress poster from FIREFLY-2 and healthcare re...

April 26, 2023, 1:31 pm

Apellis presents phase 3 functional analyses of syfovre™ (pegcetacoplan injection) for geographic atrophy

Showed visual function and quality-of-life benefits in patients with extrafoveal lesions Slowed the loss of retinal pigmented epithelial and photorece...

April 23, 2023, 10:05 pm

European parliament passes a law on cryptocurrencies

On Thursday, MEPs voted 529 to 29 with 14 abstentions to approve Markets in Crypto-assets (MiCA), a law that creates a regulatory framework for the ci...

April 21, 2023, 9:18 am

European parliament approves landmark crypto law, mica

European Union (EU) lawmakers have voted in favour of the Markets in Crypto-Assets (MiCA) regulation, making Europe the first major jurisdiction to in...

April 20, 2023, 4:48 pm

Biovie's degenerative dementia drug candidate to be presented at psychiatry conference

BioVie Inc (NASDAQ:BIVI) announced Thursday that a data abstract from its Phase 2 open-label trial of its degenerative dementia drug candidate has bee...

April 20, 2023, 10:24 am

Jazz pharmaceuticals to present advancements in neuroscience at american academy of neurology annual meeting

Eleven abstracts emphasize Jazz's leadership in neuroscience and commitment to advance understanding of sleep disorders, epilepsy and movement disorde...

April 19, 2023, 7:45 am

"chatgpt outperforms traditional sentiment analysis methods" to forecast stock prices

Here's a link to an academic paper that examined:Can ChatGPT Forecast Stock Price Movements?The abstract reads:We examine the potential of ChatGPT, an...

April 18, 2023, 12:52 am

Biovie to present phase 2 trial data abstracts at 2023 american academy of neurology annual meeting

BioVie announced that data abstracts from its Phase 2 trials evaluating NE3107 in degenerative dementias and Parkinson's disease will be presented at ...

April 17, 2023, 12:01 pm

Diacarta announces five abstracts accepted for presentation at aacr annual meeting 2023

Abstracts demonstrating XNA technology’s improvements to assay sensitivity across different technology platforms and support for use in companion di...

April 16, 2023, 6:00 pm

Context therapeutics says ctim-76 abstract accepted for presentation at aacr annual meeting, will host webinar

Context Therapeutics (NASDAQ:CNTX) Inc announced that an abstract regarding its preclinical candidate, CTIM-76, a Claudin 6 x CD3 bispecific antibody,...

April 16, 2023, 3:01 am

Outset medical to present research highlighting home hemodialysis success for underserved populations at national kidney foundation spring clinical meetings

SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company reducing the cost and complexity of ...

April 12, 2023, 9:05 am

Prelude therapeutics to present at american association for cancer research 2023 conference

Eight Abstracts Demonstrate Progress of Prelude's Differentiated Pipeline Eight Abstracts Demonstrate Progress of Prelude's Differentiated Pipeline...

April 11, 2023, 8:30 am


Search within

Pages Search Results: